G Bryant

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

Wyndham H. Wilson, G Bryant, Susan E. Bates et al. · Journal of Clinical Oncology · 1993 · 244 citations

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

Wyndham H. Wilson, Stacey L. Berg, G Bryant et al. · Journal of Clinical Oncology · 1994 · 217 citations

Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.

David Colcher, Jorge A. Carrasquillo, Paul H. Sugarbaker et al. · PubMed · 1987 · 164 citations

Intravenous Administration, Gastrointestinal Oncology, Medicine +14

Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3

David Colcher, Ann D. Thor, Jeffrey Schlom et al. · International Journal of Cancer · 1987 · 125 citations

Immunology, Immunoediting, Pathology +18

Quantitative analyses of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patients.

David Colcher, Jorge A. Carrasquillo, Paul H. Sugarbaker et al. · PubMed · 1987 · 124 citations

Monoclonal Antibody Localization, Radiolocalization Indices, Immunocytochemical Technique +17